iOnctura picks up Series A
iOnctura B.V., a Swiss clinical stage biopharmaceutical company, has raised 15 million euros in Series A financing.
iOnctura B.V., a Swiss clinical stage biopharmaceutical company, has raised 15 million euros in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination